Related Experiment Video
Updated: Jun 8, 2025
07:21
Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
Published on: June 16, 2023
854
Virtual care in patients with type 2 diabetes during covid-19
Héctor Velázquez-Jurado1, Liliana Pérez-Peralta1, Daniela Valle-Nava1
1Secretaría de Salud, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Centro de Atención Integral del Paciente con Diabetes. Ciudad de México, México.
Revista Medica Del Instituto Mexicano Del Seguro Social
|November 7, 2024
Summary
Virtual and in-person care for type 2 diabetes mellitus (T2DM) showed similar benefits during the COVID-19 pandemic. Remote consultations offer a safe and effective alternative for managing T2DM.
Area of Science:
- Endocrinology
- Diabetes Management
- Public Health
Background:
- The COVID-19 pandemic presented challenges for self-management in type 2 diabetes mellitus (T2DM).
- Remote care modalities were adopted by some health services for chronic illness management.
Purpose of the Study:
- To compare in-person (AP) versus virtual (AV) care modalities for T2DM during the COVID-19 pandemic.
- To assess the impact of care modalities on clinical and mental health variables.
Main Methods:
- Prospective cohort study of 75 T2DM patients (mean age 49) from June 2020 to December 2021.
- 40 patients received virtual attention (VA) and 35 received in-person attention (AP).
- Statistical analysis included Chi-square, Mann-Whitney U, and Friedman tests.
Main Results:
- Both AP and VA groups showed reductions in HbA1c, triglycerides, and Non-HDL cholesterol.
- Quality of life and emotional exhaustion improved in both groups.
- Good quality of life and triglyceride control at two months predicted better HbA1c control.
Conclusions:
- Both in-person and virtual care modalities provide comparable benefits for T2DM management.
- Virtual consultation proved to be a safe and effective alternative during the pandemic.
More Related Videos
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
01:15Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
01:15Diabetes: Symptoms, Diagnosis, and Complications
508
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
508
01:22Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
01:20Pathophysiology of Diabetes
872
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
01:29Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70